| The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States M Zhdanava, D Pilon, I Ghelerter, W Chow, K Joshi, P Lefebvre, ... The Journal of Clinical Psychiatry 82 (2), 29169, 2021 | 227 | 2021 |
| Recent trends in the prevalence of type 2 diabetes and the association with abdominal obesity lead to growing health disparities in the USA: an analysis of the NHANES surveys … H Caspard, S Jabbour, N Hammar, P Fenici, JJ Sheehan, M Kosiborod Diabetes, Obesity and Metabolism 20 (3), 667-671, 2018 | 152 | 2018 |
| Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review V Vaidya, N Gangan, J Sheehan Expert review of pharmacoeconomics & outcomes research 15 (3), 487-497, 2015 | 145 | 2015 |
| Fibrin‐modifying serine proteases thrombin, tPA, and plasmin in ischemic stroke: a review JJ Sheehan, SE Tsirka Glia 50 (4), 340-350, 2005 | 123 | 2005 |
| A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated … RL Findling, R Mankoski, K Timko, K Lears, T McCartney, RD McQuade, ... The Journal of clinical psychiatry 75 (1), 16656, 2014 | 118 | 2014 |
| Atypical antipsychotic metabolism and excretion JJ Sheehan, JK Sliwa, JC Amatniek, A Grinspan, CM Canuso Current drug metabolism 11 (6), 516-525, 2010 | 110 | 2010 |
| Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice JJ Sheehan, C Zhou, I Gravanis, AD Rogove, YP Wu, DF Bogenhagen, ... Journal of Neuroscience 27 (7), 1738-1745, 2007 | 110 | 2007 |
| Association between hospitalization for heart failure and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: an observational study AZ Fu, SS Johnston, A Ghannam, K Tsai, K Cappell, R Fowler, E Riehle, ... Diabetes care 39 (5), 726-734, 2016 | 95 | 2016 |
| Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus AM Farr, JJ Sheehan, SM Curkendall, DM Smith, SS Johnston, I Kalsekar Advances in therapy 31, 1287-1305, 2014 | 93 | 2014 |
| Le H. Economic burden among patients with major depressive disorder: an analysis of healthcare resource use, work productivity, and direct and indirect costs by depression severity W Chow, MJ Doane, J Sheehan, L Alphs, H Le Am J Manag Care 16, e188-e196, 2019 | 71 | 2019 |
| Comparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalents JJ Sheehan, KR Reilly, DJ Fu, L Alphs Innovations in Clinical Neuroscience 9 (7-8), 17, 2012 | 68 | 2012 |
| All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population G Li, D Fife, G Wang, JJ Sheehan, R Bodén, L Brandt, P Brenner, ... Annals of General Psychiatry 18, 1-8, 2019 | 63 | 2019 |
| Treatment intensification for patients with type 2 diabetes and poor glycaemic control AZ Fu, JJ Sheehan Diabetes, Obesity and Metabolism 18 (9), 892-898, 2016 | 54 | 2016 |
| Burden of treatment-resistant depression in Medicare: a retrospective claims database analysis D Pilon, K Joshi, JJ Sheehan, ML Zichlin, P Zuckerman, P Lefebvre, ... PLoS One 14 (10), e0223255, 2019 | 38 | 2019 |
| Efficacy and safety of paliperidone extended-release in schizophrenia patients with prominent affective symptoms CM Canuso, I Turkoz, JJ Sheehan, CA Bossie Journal of affective disorders 120 (1-3), 193-199, 2010 | 36 | 2010 |
| Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid. SA Seabury, DP Goldman, I Kalsekar, JJ Sheehan, K Laubmeier, ... The American Journal of Managed Care 20 (2), e52-60, 2014 | 33 | 2014 |
| Evaluating the quality of comprehensive cardiometabolic care for patients with type 2 diabetes in the US: the Diabetes Collaborative Registry SV Arnold, SE Inzucchi, DK McGuire, SN Mehta, A Goyal, LS Sperling, ... Diabetes Care 39 (7), e99-e101, 2016 | 31 | 2016 |
| Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression I Turkoz, L Alphs, J Singh, C Jamieson, E Daly, M Shawi, JJ Sheehan, ... Acta Psychiatrica Scandinavica 143 (3), 253-263, 2021 | 30 | 2021 |
| Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression I Turkoz, DJ Fu, CA Bossie, JJ Sheehan, L Alphs Journal of affective disorders 150 (1), 17-22, 2013 | 28 | 2013 |
| Management of antipsychotic treatment discontinuation and interruptions using model-based simulations MN Samtani, JJ Sheehan, DJ Fu, B Remmerie, JK Sliwa, L Alphs Clinical Pharmacology: Advances and Applications, 25-40, 2012 | 27 | 2012 |
Dominic PilonVice President, Analysis Group, Inc.Bestätigte E-Mail-Adresse bei analysisgroup.com
